Further, MMP-2 expression increases and co-localizes with tau pathology in the entorhinal cortex at early stages of AD-related pathology, which is likely a response geared to eliminating production of toxic truncated tau species in Alzheimer’s-diseased brains [229]. Here, MMP2 is linked to Alzheimer disease.